EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+3.74%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$2.09B
AUM Growth
+$101M
(+5.1%)
Cap. Flow
+$51.3M
Cap. Flow
% of AUM
2.45%
Top 10 Holdings %
Top 10 Hldgs %
52.15%
Holding
437
New
42
Increased
236
Reduced
93
Closed
39
Top Buys
| 1 |
Apple
AAPL
|
$22.7M |
| 2 |
Microsoft
MSFT
|
$17M |
| 3 |
NVIDIA
NVDA
|
$15.1M |
| 4 |
Amazon
AMZN
|
$13.7M |
| 5 |
Meta Platforms (Facebook)
META
|
$13.3M |
Top Sells
| 1 |
Pinduoduo
PDD
|
$95M |
| 2 |
KE Holdings
BEKE
|
$15.8M |
| 3 |
Full Truck Alliance
YMM
|
$10.2M |
| 4 |
Tencent Music
TME
|
$10M |
| 5 |
TSMC
TSM
|
$8.26M |
Sector Composition
| 1 | Technology | 37.79% |
| 2 | Consumer Discretionary | 26.64% |
| 3 | Communication Services | 10.64% |
| 4 | Healthcare | 6.89% |
| 5 | Financials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Invesco NASDAQ 100 ETF
QQQM
$59.2B
| $275K | 0.01% |
+1,424
| New | +$275K |
|
327
First Solar
FSLR
$21.7B
| $274K | 0.01% |
2,169
| – | – |
|
328
PTC Therapeutics
PTCT
$4.61B
| $272K | 0.01% |
5,334
-186
| -3% | -$9.48K |
|
329
Biohaven
BHVN
$1.7B
| $269K | 0.01% |
11,185
+1,572
| +16% | +$37.8K |
|
330
Prologis
PLD
$105B
| $266K | 0.01% |
2,381
+88
| +4% | +$9.84K |
|
331
GE Vernova
GEV
$163B
| $265K | 0.01% |
869
-4,083
| -82% | -$1.25M |
|
332
Howmet Aerospace
HWM
$72.4B
| $265K | 0.01% |
2,041
-7,097
| -78% | -$921K |
|
333
AutoZone
AZO
$70.8B
| $263K | 0.01% |
+69
| New | +$263K |
|
334
Blackstone
BX
$133B
| $263K | 0.01% |
1,879
+128
| +7% | +$17.9K |
|
335
Altria Group
MO
$112B
| $262K | 0.01% |
4,358
+163
| +4% | +$9.78K |
|
336
Southern Company
SO
$101B
| $259K | 0.01% |
2,817
+105
| +4% | +$9.66K |
|
337
Intercontinental Exchange
ICE
$99.9B
| $259K | 0.01% |
1,500
+61
| +4% | +$10.5K |
|
338
Agios Pharmaceuticals
AGIO
$2.1B
| $256K | 0.01% |
+8,750
| New | +$256K |
|
339
Sherwin-Williams
SHW
$91.2B
| $250K | 0.01% |
716
+5
| +0.7% | +$1.75K |
|
340
CME Group
CME
$96.4B
| $246K | 0.01% |
927
+35
| +4% | +$9.29K |
|
341
Akamai
AKAM
$11.1B
| $245K | 0.01% |
3,049
| – | – |
|
342
Welltower
WELL
$112B
| $244K | 0.01% |
+1,590
| New | +$244K |
|
343
Travere Therapeutics
TVTX
$1.89B
| $243K | 0.01% |
13,553
+1,072
| +9% | +$19.2K |
|
|
JNPR
344
DELISTED
Juniper Networks
JNPR
| $243K | 0.01% |
6,703
| – | – |
|
345
Lockheed Martin
LMT
$107B
| $242K | 0.01% |
542
+20
| +4% | +$8.93K |
|
346
Catalyst Pharmaceutical
CPRX
$2.42B
| $237K | 0.01% |
+9,785
| New | +$237K |
|
347
Arcutis Biotherapeutics
ARQT
$1.94B
| $234K | 0.01% |
14,987
+108
| +0.7% | +$1.69K |
|
348
Arrowhead Research
ARWR
$3.87B
| $230K | 0.01% |
+18,017
| New | +$230K |
|
349
Immunovant
IMVT
$2.81B
| $222K | 0.01% |
12,975
+4,725
| +57% | +$80.8K |
|
350
Beam Therapeutics
BEAM
$1.88B
| $219K | 0.01% |
+11,203
| New | +$219K |
|